The therapeutic relevance of this pathway is underscored by studies showing that genetic knockdown of TLR4 or its downstream effector COX-2 significantly impairs PCa cell proliferation, migration, and invasion by inhibiting the phosphorylation and activation of NF-κB p65 [34, 35]. This evidence concerns the gene NFKB1 and posterior cortical atrophy.